A study led by Kaiser Permanente in Southern California of patients from eight health care organizations across the United States showed that COVID-19 was associated with a 4% increase in use of health care services over ...
Aug 12, 2022
0
6
"Don't poke the bear," they said. But that's exactly what a team of scientists have been doing to discover the secrets of blood clotting.
Apr 13, 2023
0
16
A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic ...
Sep 15, 2021
0
11
Atopic dermatitis (AD) in adulthood is associated with an increased risk for venous thromboembolism (VTE), according to a study published online May 31 in JAMA Dermatology.
Jun 1, 2023
0
0
Patients with inflammatory bowel disease (IBD) undergoing surgery may be more likely to develop deep vein thrombosis (DVT; blood clot in a deep vein in the thigh or leg) or pulmonary embolism (PE; blood clot in blood vessels ...
Oct 17, 2011
0
0
Jefferson researchers identified a high risk for venous thromboembolism (VTE), or blood clots, following surgery for long-bone reconstruction in patients with metastatic cancer. They published the results in the Journal of ...
Sep 19, 2015
0
16
A new type of anti-clotting drug called semuloparin has been found to reduce the development of potentially fatal blood clots in the veins that often occur in cancer patients, doctors at Duke Cancer Institute and elsewhere ...
Jun 7, 2011
0
0
(HealthDay)—A single dose of low-molecular-weight heparin (LMWH) given the previous day can reduce D-dimer and potentially risk non-identification of a deep vein thrombosis (DVT), according to a research letter published ...
Dec 22, 2016
0
0
The direct oral anticoagulant rivaroxaban dramatically cut the likelihood of serious venous thromboembolism (VTE) in people recovering from lower limb orthopedic surgery requiring immobilization in comparison with enoxaparin, ...
Mar 30, 2020
0
1
In a preliminary clinical trial, investigators at Johns Hopkins have shown that even partially-matched bone marrow transplants can eliminate sickle cell disease in some patients, ridding them of painful and debilitating symptoms, ...
Sep 20, 2012
0
0
